OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Telos Corp. engages in the design and provision of advanced technologies to deliver solutions that empower and protect the demanding enterprises. Its solutions include cyber security, cyber risk management and compliance, secure mobility, identity management, and information technology and enterprise solutions. The company was founded in October 1971 and is headquartered in Ashburn, VA.

Sow Good, Inc. engages in the provision of freeze-dried snacks, smoothies, soups, and granola. Its two distinct brands include Sow Good and Sustain Us. The company was founded by Ira Goldfarb and Claudia Goldfarb on April 9, 2010 and is headquartered in Irving, TX.

NANO Nuclear Energy Inc. operates as a microreactor technology company. The company is developing ZEUS, a solid-core battery reactor, and ODIN, a low-pressure coolant reactor. It is also developing a high-assay low-enriched uranium fabrication facility to supply fuel to the nuclear reactor industry and fuel transportation and nuclear consultation businesses. The company was founded in 2021 and is based in New York, New York.

Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.

Kuke Music Holding Ltd. is an investment holding company, which engages in the distribution of commercial copyrights, provision of music education solutions, sales of musical instruments, and provision of services related to music events and performances. It operates through the following business segments: Subscription, Licensing, and Smart Education, and Music Events and Performances. The Subscription, Licensing, and Smart Education segment distributes commercial copyrights and provision of music education solutions. The Music Events and Performances segment offers services related to music festival events and music performance and sale of Conch Smart Speakers. The company was founded by Yu He in 2007 and is headquartered in Beijing, China.

HMN Financial, Inc. is a stock savings bank holding company which operates retail banking and loan production facilities in Minnesota, Iowa, and Wisconsin. The firm's business involves attracting deposits from the general public and businesses and using such deposits to originate or purchase single family residential, commercial real estate and multi-family mortgage loans as well as consumer, construction and commercial business loans. It also invests in mortgage-backed and related securities, U.S. government agency obligations, and other permissible investments. The company was founded in 1994 and is headquartered in Rochester, MN.

WiSA Technologies, Inc. engages in the manufacturing of modules which wirelessly transmit and receive audio directly to speakers. Its products include Summit TX-SD, Summit RX-SD, TX Dev Kit, RX Dev Kit, 30 Watt Amp, and DAC board. The company was founded on July 23, 2010 and is headquartered in Beaverton, OR.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.